These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4192861)

  • 21. [Effect of nicotinamide on focal and generalized epileptic activity in the cerebral cortex].
    Braslavskiĭ VE; Shchavelev VA; Kryzhanovskiĭ GN; Nikushkin EV; Germanov SB
    Biull Eksp Biol Med; 1982 Aug; 94(8):39-42. PubMed ID: 6215072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.
    Neuwelt EA; Pagel M; Barnett P; Glassberg M; Frenkel EP
    Cancer Res; 1981 Nov; 41(11 Pt 1):4466-70. PubMed ID: 6796261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia.
    Gurses C; Ekizoglu O; Orhan N; Ustek D; Arican N; Ahishali B; Elmas I; Kucuk M; Bilgic B; Kemikler G; Kalayci R; Karadeniz A; Kaya M
    Brain Res; 2009 Jul; 1281():71-83. PubMed ID: 19464270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravenous application of hylase "Dessau" on the blood-brain barrier].
    Senitz D; Fischer GJ
    Exp Pathol (Jena); 1972; 7(5):228-33. PubMed ID: 4660914
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis.
    Boje KM
    Brain Res; 1996 May; 720(1-2):75-83. PubMed ID: 8782899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
    Neuwelt EA; Glasberg M; Frenkel E; Barnett P
    Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An attempt to establish penicillin-induced chronic epileptic foci in avian brain.
    Ghosh S; Maiti AK
    Indian J Exp Biol; 1980 Nov; 18(11):1302-5. PubMed ID: 7216291
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lesions of the blood-brain barrier in chronic experimental epilepsy].
    Moene Y; Bello S; Revol M
    C R Seances Soc Biol Fil; 1968 Nov; 162(4):918-23. PubMed ID: 4235897
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes of the course of experimental epileptic attacks by curarization].
    Fournau P; Four E; Riotte M
    C R Seances Soc Biol Fil; 1980; 174(3):320-4. PubMed ID: 6448675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in modulating blood brain barrier permeability by NO in pentylenetetrazol-induced epileptic seizures.
    Diler AS; Uzüm G; Akgün Dar K; Aksu U; Atukeren P; Ziylan YZ
    Life Sci; 2007 Mar; 80(14):1274-81. PubMed ID: 17306837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development and propagation of provoked convulsive activity caused by an intracortical injection of penicillin].
    Alcaraz M; Guzmán-Flcres C
    Gac Med Mex; 1970 Jun; 100(6):641-51. PubMed ID: 5452754
    [No Abstract]   [Full Text] [Related]  

  • 32. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy.
    Ravizza T; Gagliardi B; Noé F; Boer K; Aronica E; Vezzani A
    Neurobiol Dis; 2008 Jan; 29(1):142-60. PubMed ID: 17931873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development.
    Stolp HB; Ek CJ; Johansson PA; Dziegielewska KM; Potter AM; Habgood MD; Saunders NR
    Eur J Neurosci; 2007 Dec; 26(12):3465-74. PubMed ID: 18088277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epileptic focus in the forebrain of the turtle.
    Volanschi D; Servít Z
    Exp Neurol; 1969 May; 24(1):137-46. PubMed ID: 5771102
    [No Abstract]   [Full Text] [Related]  

  • 35. Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier.
    Bowyer JF; Thomas M; Schmued LC; Ali SF
    Ann N Y Acad Sci; 2008 Oct; 1139():127-39. PubMed ID: 18991857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anticonvulsant activity of acetone does not depend upon its metabolites.
    Gasior M; Hartman AL; Rogawski MA
    Epilepsia; 2008 May; 49(5):936-7. PubMed ID: 18454785
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification.
    Neuwelt EA; Barnett PA; Glasberg M; Frenkel EP
    Cancer Res; 1983 Nov; 43(11):5278-85. PubMed ID: 6193870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity of iothalamates and diatrizoates. II. Historadioautographic study of rat brains with 131-Iodine-tagged contrast media.
    Tuohimaa PJ; Melartin E
    Invest Radiol; 1970; 5(1):22-9. PubMed ID: 5434792
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of pyridoxal-5-phosphate on epileptic activity in the cerebral cortex].
    Kryzhanovskiĭ GN; Shandra AA; Godlevskiĭ LS
    Farmakol Toksikol; 1981; 44(2):136-40. PubMed ID: 7274421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interpretation of the mechanism of the monoamine barrier in the cerebral capillaries].
    Donáth T; Tauber F
    Morphol Igazsagugyi Orv Sz; 1974 Oct; 14(4):273-9. PubMed ID: 4427600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.